Home / Inspections / 1176107

FDA Inspection 1176107 — Genzyme Corporation

Genzyme Corporation — FEI 1220423

The FDA completed an inspection of Genzyme Corporation on July 25, 2022 in Framingham, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Framingham, MA (United States)

Facility

Other inspections at this facility

  • 1294652 (VAI Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232210 (OAI Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003362 (NAI Thu Feb 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904958 (VAI Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897241 (VAI Thu Sep 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources